InvestorsHub Logo
Followers 26
Posts 6549
Boards Moderated 4
Alias Born 03/20/2017

Re: None

Saturday, 09/19/2020 7:30:19 AM

Saturday, September 19, 2020 7:30:19 AM

Post# of 50
In my research on this company, and in what they have to offer, I was astounded to find that they have discovered an entirely new delivery "platform" that can be utilized to deliver cannabis medications that until now was seldom if ever explored.

For example, the reason CBD is taken by eyedropper under the tongue is because the human digestive system breaks down CBD before the body ever has the opportunity to absorb it. What little is absorbed, is only a fraction of what one takes, and that amount varies for every single human being.

Lexaria Biosciences found they could combine CBD with long chain fatty acids thereby by-passing the normal digestive degradation (long chain fatty acids are a normal and natural part of our everyday foods). This delivery approach opens entirely new frontiers for medication delivery, and facilitates nearly full absorption. In effect, Lexaria now has a "platform" that can be utilized to deliver a whole host of products never before considered. The possibilities are endless.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.